News for Healthier Living

Tirzepatide More Cost-Effective Than Semaglutide in Patients with Knee Osteoarthritis and Obesity

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual care, diet and exercise, and weight loss surgeries.

September 15, 2025


September 16 2025

September 15 2025

September 14 2025

September 13 2025

September 12 2025

September 11 2025

September 10 2025

September 9 2025

September 8 2025

September 7 2025

September 6 2025

September 5 2025

September 4 2025

September 3 2025

September 2 2025